News
-
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. (NYSE-American:VTAK) Expands Sales Team; Expects Corresponding Rise in Revenue Over the Near Term; Anticipates Breakeven by End of Year
Catheter Precision, Inc. announces major expansion in business development team to drive growth and market penetration in cardiac electrophysiology. Hiring experienced industry veterans and technical experts -
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. (NYSE American:VTAK) Releases Operational Performance Report, Q4 and Annual 2023 Financials for Year Ending December 31, 2023
Catheter Precision, Inc. releases Q4 and Annual Financials for 2023, showcasing revenue growth. Achievements in clinical data and IP advancements noted -
-
-
-